![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, December 07, 2003 12:59:14 PM
Although this is my first post, I've enjoyed reading the thread for the past month or so!
I have purchased DNAP shares over the past 30 days and believe I'll be buying more this week. As you know, their story is truly compelling and I "hope" that their proprietary items realize the value that we think they should!
OVANOME: what's the latest on this? The last info I can locate is the 12-02 newsletter from Tony. It states "We are in the process of executing a blind validation of OVANOME performance.....we could have our first drug classifier product on the market soon". Prior to that, is the 3-14-02 PR on the positive results reported at BioITWorld Expo in Boston.
If effective, IMO, this will be a huge coming out party for DNAP in the personalized medicine arena. I could see them charging $1,000+ for this test. Are yearly diagnoses around 14,000 for ovarian cancer? If so, at 50% testing = $7 mill annual revenues! ($3.5M to $5M profits?)
I apologize for asking for info that's probably been discussed before! TIA as I'll be posting lightly on my 3 alloted posts for today!
Mike
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM